CAS NO:357166-30-4

EC NO:

Molecular Formula:C₂₀H₂₁N₅Na₂O₇

Molecular Weight:489.38958

Synonyms:;N-[4-[2-(2-Amino-4,7-dihydro-4-oxo-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]-L-glutamic acid disodium salt hydrate;Pemetrexed disodium 2.5H2O;2-[4-[2-(4-Amino-2-oxo-3,5,7-triazabicyclo[4.3.0]nona-3,8,10-trien-9-yl)ethyl]benzoyl]aminopentanedioic acid disodium salt hydrate;Pemetrexed Disodium hemipenta hydrate;Pemetrexed disodium hemipentahydrate;

Molecular Structure:

CAS NO:357166-29-1

EC NO:

Molecular Formula:C₂₀H₁₉N₅Na₂O₆·7(H₂O)

Molecular Weight:597.49

Synonyms:;Pemetrexed disodium hepthydrate;Pemetrexed disodium heptahydrate;N-[4-[2-(2-Amino-4,7-dihydro-4-oxo-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]-L-glutamic acid disodium salt hydrate;

Molecular Structure:

CAS NO:82104-74-3

EC NO:279-900-2

Molecular Formula:C₉H₅NO₂

Molecular Weight:159.1415

Synonyms:;5-Cyano-3h-Isobenzofuranone;1,3-Dihydro-1-Oxo-5-Isobenzofurancarbonitrile;1,3-Dihydro-1-Oxoisobenzofuran-5-Carbonitrile;1-Oxo-1,3-Dihydro-2-Benzofuran-5-Carbonitrile;5-Phthalidenitrile;5-Cyano-Phthalide;5-Cyanophthaleine;5-Cyano phthalide;1-Oxo-1,3-dihydroisobenzofuran-5-carbonitrile;

Molecular Structure:

CAS NO:821-06-7

EC NO:212-472-7

Molecular Formula:C₄H₆Br₂

Molecular Weight:213.9

Synonyms:;(e)-1,4-dibromobut-2-ene;(E)-1,4-Dibromo-2-butene;1,4-dibromo-, trans-;trans-Dibromobutene;trans-1,4-Dibromobut-2-ene;1,4-trans-Dibromobutene-2;1,4-Dibromo-2-butene, E;(2E)-1,4-Dibromo-2-butene;Trans1,4-Dibromo-2-Butylene;2-Butene, 1,4-dibromo-, (2E)-;DBB;(2E)-1,4-dibromobut-2-ene;

Molecular Structure:

CAS NO:161715-24-8

EC NO:

Molecular Formula:C₂₂H₃₁N₃O₆S₂

Molecular Weight:497.628

Synonyms:;Tebipenem pivoxil;L-084;Tebipenam Pivoxil;[(2,2-dimethylpropanoyl)oxy]methyl (4R,5S,6S)-3-{[1-(4,5-dihydro-1,3-thiazol-2-yl)azetidin-3-yl]sulfanyl}-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate;

Molecular Structure:

CAS NO:341031-54-7

EC NO:

Molecular Formula:C₂₈H₃₈N₄O₇

Molecular Weight:542.62392

Synonyms:;SUNITINIB MALEATE;1H-Pyrrole-3-carboxamide, N-(2-(diethylamino)ethyl)-5-((Z)- (5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl)-2,4- dimethyl-, (2S)-hydroxybutanedioate (1:1);Butanedioic acid, hydroxy-, (2S)-, compd. with N-(2- (diethylamino)ethyl)-5-((Z)-(5-fluoro-1,2-dihydro-2-oxo-3H- indol-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3- carboxamide (1:1);N-(2-(Diethylamino)ethyl)-5-((Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxamide (2S)-hydroxybutanedioate;(2S)-2-hydroxybutanedioic acid - N-[2-(diethylamino)ethyl]-5-[(Z)-(5-fluoro-2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide (1:1);2-hydroxypentanedioic acid - N-[2-(diethylamino)ethyl]-2,4-dimethyl-5-[(Z)-(5-methyl-2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-1H-pyrrole-3-carboxamide (1:1);Sunitinib Mablate;

Molecular Structure:

CAS NO:341031-54-7

EC NO:

Molecular Formula:C₂₈H₃₈N₄O₇

Molecular Weight:542.62392

Synonyms:;SUNITINIB MALEATE;1H-Pyrrole-3-carboxamide, N-(2-(diethylamino)ethyl)-5-((Z)- (5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl)-2,4- dimethyl-, (2S)-hydroxybutanedioate (1:1);Butanedioic acid, hydroxy-, (2S)-, compd. with N-(2- (diethylamino)ethyl)-5-((Z)-(5-fluoro-1,2-dihydro-2-oxo-3H- indol-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3- carboxamide (1:1);N-(2-(Diethylamino)ethyl)-5-((Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxamide (2S)-hydroxybutanedioate;(2S)-2-hydroxybutanedioic acid - N-[2-(diethylamino)ethyl]-5-[(Z)-(5-fluoro-2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide (1:1);2-hydroxypentanedioic acid - N-[2-(diethylamino)ethyl]-2,4-dimethyl-5-[(Z)-(5-methyl-2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-1H-pyrrole-3-carboxamide (1:1);Sunitinib Mablate;

Molecular Structure:

CAS NO:341031-54-7

EC NO:

Molecular Formula:C₂₈H₃₈N₄O₇

Molecular Weight:542.62392

Synonyms:;SUNITINIB MALEATE;1H-Pyrrole-3-carboxamide, N-(2-(diethylamino)ethyl)-5-((Z)- (5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl)-2,4- dimethyl-, (2S)-hydroxybutanedioate (1:1);Butanedioic acid, hydroxy-, (2S)-, compd. with N-(2- (diethylamino)ethyl)-5-((Z)-(5-fluoro-1,2-dihydro-2-oxo-3H- indol-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3- carboxamide (1:1);N-(2-(Diethylamino)ethyl)-5-((Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxamide (2S)-hydroxybutanedioate;(2S)-2-hydroxybutanedioic acid - N-[2-(diethylamino)ethyl]-5-[(Z)-(5-fluoro-2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide (1:1);2-hydroxypentanedioic acid - N-[2-(diethylamino)ethyl]-2,4-dimethyl-5-[(Z)-(5-methyl-2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-1H-pyrrole-3-carboxamide (1:1);Sunitinib Mablate;

Molecular Structure: